Ningbo David Medical Device Co Ltd (300314) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Ningbo David Medical Device Co Ltd (300314) has a cash flow conversion efficiency ratio of 0.120x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥146.39 Million ≈ $21.42 Million USD) by net assets (CN¥1.22 Billion ≈ $178.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Ningbo David Medical Device Co Ltd worth for the company's overall valuation and market capitalisation.
Ningbo David Medical Device Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Ningbo David Medical Device Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Ningbo David Medical Device Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Ningbo David Medical Device Co Ltd ranked by their cash flow conversion efficiency. Explore Ningbo David Medical Device Co Ltd (300314) cash flow quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ovid Therapeutics Inc
NASDAQ:OVID
|
-0.070x |
|
Suzhou Kelida Bldg &
SHG:603828
|
0.085x |
|
First Foundation Inc.
NYSE:FFWM
|
-0.027x |
|
Irish Residential Properties
IR:IRES
|
0.019x |
|
Qingdao Copton Technology Co Ltd
SHG:603798
|
0.016x |
|
Wajax Corporation
TO:WJX
|
0.026x |
|
Masoval AS
OL:MAS
|
0.159x |
|
AgomAb Therapeutics NV American Depositary Shares
NASDAQ:AGMB
|
-0.085x |
Annual Cash Flow Conversion Efficiency for Ningbo David Medical Device Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Ningbo David Medical Device Co Ltd from 2008 to 2025. View 300314 stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.23 Billion ≈ $180.42 Million |
CN¥89.25 Million ≈ $13.06 Million |
0.072x | -9.91% |
| 2024-12-31 | CN¥1.17 Billion ≈ $170.96 Million |
CN¥93.87 Million ≈ $13.74 Million |
0.080x | -30.86% |
| 2023-12-31 | CN¥1.16 Billion ≈ $170.25 Million |
CN¥135.20 Million ≈ $19.78 Million |
0.116x | +10.33% |
| 2022-12-31 | CN¥1.06 Billion ≈ $155.01 Million |
CN¥111.57 Million ≈ $16.33 Million |
0.105x | +102.65% |
| 2021-12-31 | CN¥990.53 Million ≈ $144.95 Million |
CN¥51.48 Million ≈ $7.53 Million |
0.052x | -64.02% |
| 2020-12-31 | CN¥953.52 Million ≈ $139.53 Million |
CN¥137.73 Million ≈ $20.15 Million |
0.144x | +35.17% |
| 2019-12-31 | CN¥828.85 Million ≈ $121.29 Million |
CN¥88.57 Million ≈ $12.96 Million |
0.107x | +21.09% |
| 2018-12-31 | CN¥792.71 Million ≈ $116.00 Million |
CN¥69.95 Million ≈ $10.24 Million |
0.088x | +25.47% |
| 2017-12-31 | CN¥778.30 Million ≈ $113.89 Million |
CN¥54.74 Million ≈ $8.01 Million |
0.070x | -31.58% |
| 2016-12-31 | CN¥748.55 Million ≈ $109.54 Million |
CN¥76.95 Million ≈ $11.26 Million |
0.103x | +48.20% |
| 2015-12-31 | CN¥697.90 Million ≈ $102.12 Million |
CN¥48.41 Million ≈ $7.08 Million |
0.069x | -31.55% |
| 2014-12-31 | CN¥668.97 Million ≈ $97.89 Million |
CN¥67.79 Million ≈ $9.92 Million |
0.101x | +12.68% |
| 2013-12-31 | CN¥628.16 Million ≈ $91.92 Million |
CN¥56.49 Million ≈ $8.27 Million |
0.090x | -43.67% |
| 2012-12-31 | CN¥592.09 Million ≈ $86.64 Million |
CN¥94.53 Million ≈ $13.83 Million |
0.160x | -60.87% |
| 2011-12-31 | CN¥164.25 Million ≈ $24.03 Million |
CN¥67.02 Million ≈ $9.81 Million |
0.408x | -20.74% |
| 2010-12-31 | CN¥110.28 Million ≈ $16.14 Million |
CN¥56.78 Million ≈ $8.31 Million |
0.515x | -0.62% |
| 2009-12-31 | CN¥79.57 Million ≈ $11.64 Million |
CN¥41.22 Million ≈ $6.03 Million |
0.518x | +253.06% |
| 2008-12-31 | CN¥82.46 Million ≈ $12.07 Million |
CN¥12.10 Million ≈ $1.77 Million |
0.147x | -- |
About Ningbo David Medical Device Co Ltd
Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It offers infusion pumps, transcutaneous jaundice detector… Read more